경남제약

053950KOSDAQ

68.6 / 100

Reference Date: 2026-09-08

Financial Score20.0 / 40

News Sentiment19.6 / 25

Momentum17.0 / 20

Disclosure12.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Surged 34.8% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Gyeongnam Pharmaceutical primarily operates in the manufacturing and sales of pharmaceuticals, raw materials, and health functional foods, distributing products like Lemona, Jaha Saengryeok, and Minol. In 2025, revenue reached 55.9 billion won, a decrease of approximately 8% compared to the previous period, though the Lemona food product line continues to show steady growth. The company is expanding its business through online marketing and broadening its distribution channels.

Number of Employees

238people

Average Salary

53.7M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 15.004.0Point

PBR

0.39Industry Average 1.207.0Point

Half of industry avg (excellent)

ROE

-8.06Industry Average 8.000.0Point

Well below industry avg

Debt Ratio

1.01Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20251.0 / 10 points

Revenue Growth Rate

0.0 / 3

Avg ▼9.6% (2-year basis)

Operating Profit Growth Rate

1.0 / 3

Avg ▲1.2% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -7.9% (improving, 3yr)

Detailed News Sentiment

3 totalPositive 3Neutral 0Negative 0Average Sentiment Score 78.3

Positive
경남제약 ‘레모나’, 21년 연속 ‘올해의 브랜드 대상’ 수상
경남제약의 대표 브랜드 레모나가 21년 연속 비타민 부문 최고 브랜드로 선정되어 긍정적인 시장 반응을 이끌어냈다.
Positive
경남제약 ‘칼로’, 올리브영서 산리오캐릭터즈 협업 제품 출시
경남제약의 다이어트 브랜드 칼로가 산리오캐릭터즈와의 협업으로 올리브영에서 한정 출시된 신제품 출시로 긍정적인 시장 반응 예상.
Positive
경남제약 '칼로', 마시는 다이어트 건기식 '칼로-컷앤리셋' 출시
경남제약의 새로운 다이어트 건강식품 '칼로-컷앤리셋' 출시로 인해 긍정적인 시장 반응 예상.

Detailed Momentum

52-week position5.0Point

52w mid range (57%)

Current 2,170Won52-week high 3,35052-week low 564

1-month return6.0Point

1m +34.78% (strong rise)

Volume trend6.0Point

Volume surge

Detailed Disclosure

6 totalPositive 1Neutral 5Negative 0

Neutral[기재정정]주주명부폐쇄기간또는기준일설정2026-09-07
Positive[기재정정]주요사항보고서(유상증자결정)2026-09-07
Neutral[기재정정]증권신고서(지분증권)2026-09-07
Neutral주식등의대량보유상황보고서(일반)2026-08-20
Neutral반기보고서 (2026.06)2026-08-14